Total Payments
$14,225
2024 Payments
$1,804
Companies
38
Transactions
777
Medicare Patients
3,013
Medicare Billing
$222,322
Payment Breakdown by Category
Food & Beverage$14,088 (99.0%)
Education$136.82 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,088 | 769 | 99.0% |
| Education | $136.82 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,915 | 120 | $0 (2024) |
| ABBVIE INC. | $1,833 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,647 | 91 | $0 (2024) |
| Lilly USA, LLC | $1,172 | 75 | $0 (2024) |
| Allergan, Inc. | $1,114 | 76 | $0 (2020) |
| GlaxoSmithKline, LLC. | $892.88 | 45 | $0 (2024) |
| PFIZER INC. | $885.31 | 41 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $656.21 | 39 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $544.05 | 27 | $0 (2024) |
| Amgen Inc. | $430.78 | 21 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,804 | 78 | ABBVIE INC. ($489.24) |
| 2023 | $1,375 | 62 | AbbVie Inc. ($690.03) |
| 2022 | $1,562 | 82 | ABBVIE INC. ($329.16) |
| 2021 | $1,960 | 100 | AbbVie Inc. ($324.53) |
| 2020 | $1,856 | 100 | AstraZeneca Pharmaceuticals LP ($379.00) |
| 2019 | $1,738 | 109 | Allergan Inc. ($369.01) |
| 2018 | $2,357 | 131 | Novo Nordisk Inc ($365.64) |
| 2017 | $1,572 | 115 | AstraZeneca Pharmaceuticals LP ($268.42) |
All Payment Transactions
777 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $40.98 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $28.17 | General |
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $76.02 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $80.70 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $38.02 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Obesity | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 538 | 827 | $112,958 | $52,834 |
| 2022 | 14 | 687 | 1,075 | $120,622 | $57,756 |
| 2021 | 14 | 804 | 1,094 | $118,732 | $57,152 |
| 2020 | 17 | 984 | 1,300 | $135,036 | $54,580 |
Total Patients
3,013
Total Services
4,296
Medicare Billing
$222,322
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $33,500 | $16,566 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 231 | $30,030 | $12,542 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 104 | $18,200 | $8,853 | 48.6% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2023 | 30 | 155 | $17,825 | $8,282 | 46.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 32 | 45 | $5,625 | $2,686 | 47.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 18 | 18 | $1,980 | $1,370 | 69.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 18 | 18 | $700.00 | $602.82 | 86.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $620.00 | $530.08 | 85.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 17 | $1,190 | $507.36 | 42.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $1,350 | $475.20 | 35.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 38 | $1,520 | $344.96 | 22.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 22 | $418.00 | $75.02 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 281 | $36,530 | $16,049 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 108 | 108 | $27,000 | $13,712 | 50.8% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2022 | 33 | 179 | $20,585 | $10,027 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 74 | $12,950 | $6,512 | 50.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 64 | 64 | $7,040 | $5,224 | 74.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 39 | 53 | $6,625 | $2,828 | 42.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 24 | 24 | $840.00 | $719.28 | 85.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $720.00 | $684.00 | 95.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 25 | 25 | $1,250 | $444.12 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 141 | $3,384 | $417.78 | 12.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 13 | $910.00 | $369.35 | 40.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 36 | $1,440 | $344.04 | 23.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 11 | 11 | $550.00 | $281.71 | 51.2% |
About Dr. Anita Bodrogi, DO
Dr. Anita Bodrogi, DO is a General Practice healthcare provider based in Plattsburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851475487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anita Bodrogi, DO has received a total of $14,225 in payments from pharmaceutical and medical device companies, with $1,804 received in 2024. These payments were reported across 777 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($14,088).
As a Medicare-enrolled provider, Bodrogi has provided services to 3,013 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $222,322. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties General Practice, Family Medicine
- Location Plattsburgh, NY
- Active Since 10/24/2006
- Last Updated 04/10/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1851475487
Products in Payments
- VRAYLAR (Drug) $1,107
- FARXIGA (Drug) $1,070
- UBRELVY (Drug) $986.52
- TRULICITY (Drug) $727.51
- Ozempic (Drug) $670.36
- QULIPTA (Drug) $616.44
- Trintellix (Drug) $526.60
- TRELEGY ELLIPTA (Drug) $493.58
- NURTEC ODT (Drug) $373.91
- INJECTAFER (Drug) $307.63
- XARELTO (Drug) $304.05
- Victoza (Drug) $284.54
- SYMBICORT (Drug) $261.73
- Aimovig (Biological) $250.44
- ANORO (Drug) $243.51
- EUCRISA (Drug) $230.90
- MOUNJARO (Drug) $224.08
- CHANTIX (Drug) $218.72
- Saxenda (Drug) $211.89
- Rybelsus (Drug) $205.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Plattsburgh
Dr. Michael Davey, Dmd, Ph D, DMD, PH D
General Practice — Payments: $32,818
General Practice $32,818
Miss. Jennifer Plotnick, D.m.d, D.M.D
General Practice — Payments: $5,288
General Practice $5,288
Glenn Lyons, P.a, P.A
General Practice — Payments: $4,961
General Practice $4,961
Martha Breyette, Dmd, DMD
General Practice — Payments: $1,988
General Practice $1,988
Dr. Gilbert Smith, Dds, DDS
General Practice — Payments: $1,300
General Practice $1,300
Dr. Kurt Kline, Dmd, DMD
General Practice — Payments: $1,249
General Practice $1,249